CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report (2014)
- Authors:
- USP affiliated authors: DUARTE, ALBERTO JOSE DA SILVA - FM ; PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1016/j.bcmd.2014.07.005
- Subjects: LEUCEMIA; ANTÉNOS; GLICOPROTEÍNAS
- Language: Inglês
- Imprenta:
- Publisher place: California
- Date published: 2014
- Source:
- Título do periódico: Blood Cells, Molecules, and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 53, n. 4, p. 180-184, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
VASCONCELOS, Dewton de Moraes et al. CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report. Blood Cells, Molecules, and Diseases, v. 53, n. 4, p. 180-184, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.07.005. Acesso em: 19 abr. 2024. -
APA
Vasconcelos, D. de M., Beitler, B., Martinez, G. A., Pereira, J., Amigo Filho, J. U., Klautau, G. B., et al. (2014). CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report. Blood Cells, Molecules, and Diseases, 53( 4), 180-184. doi:10.1016/j.bcmd.2014.07.005 -
NLM
Vasconcelos D de M, Beitler B, Martinez GA, Pereira J, Amigo Filho JU, Klautau GB, Lian YC, Della Negra M, Duarte AJ da S. CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report [Internet]. Blood Cells, Molecules, and Diseases. 2014 ; 53( 4): 180-184.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.bcmd.2014.07.005 -
Vancouver
Vasconcelos D de M, Beitler B, Martinez GA, Pereira J, Amigo Filho JU, Klautau GB, Lian YC, Della Negra M, Duarte AJ da S. CD18 deficiency evolving to megakaryocytic (M7) acute myeloid leukemia: Case report [Internet]. Blood Cells, Molecules, and Diseases. 2014 ; 53( 4): 180-184.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.bcmd.2014.07.005 - Chronic activation profile of circulating CD8+T cells in Sezary syndrome
- Small RNA profiling in an HTLV-1-infected patient with acute adult T-cell leukemia-lymphoma at diagnosis and after maintenance therapy: a case study
- Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor gamma-chain using massively parallel sequencing: A pilot study
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- Bortezomib (Btz) dose intensity is the strongest predictor for overall survival (OS) in mantle cell lymphoma (MCL) patients (Pts) not considered for transplantation, receiving frontline Btz plus rituximab, cyclosphosphamide, doxorubicin, and prednisone (VR-CAP) therapy in the phase 3 LYM 3002 study
- Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma
Informações sobre o DOI: 10.1016/j.bcmd.2014.07.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
